Journal profile

Journal of Pharmacoeconomics and Pharmaceutical Management

ISSN 2383-4498 · Tehran University of Medical Sciences · Iran, Islamic Republic of

Journal of Pharmacoeconomics and Pharmaceutical Management: diamond open access (no APC); no APC; review about 12 weeks (community reports); 23 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 12 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year232025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Pharmacoeconomics and Pharmaceutical Management is published by Tehran University of Medical Sciences. By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Healthcare Systems and Reforms, together about 51.5% of its articles. Its main subfields are Economics and Econometrics. (generated from OpenAlex topic counts and CAS ranking data)

Journal of Pharmacoeconomics and Pharmaceutical Management (JPPM) is an international peer-reviewed journal, which publishes original research articles, reviews, letters and editorials on all fields of pharmacoeconomics, and pharmaceutical management. JPPM is dedicated to the clear communication of policy and economic issues related to pharmaceutical system, pharmaceutical industries, patient services and rational use of medicines. Aims and Scope The aim of JPPM is to provide an opportunity for publication and dissemination of studies in all fields of pharmacoeconomics and pharmaceutical management studies. It targets to publish most complete and reliable source of information on all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. The areas of interest include: All types of economic evaluation studies (cost effectiveness analysis/ cost utility analysis/ cost benefit analysis) Economic analysis of Pharmaceutical policies. Cost of illness studies. Evaluation of pharmacoeconomic methodologies. Analysis of pharmaceutical pricing policies. Analysis of pharmaceutical reimbursement policies. outcomes research and quality-of-life assessments Prescribing decisions Analysis of pharmaceutical markets All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication. Articles published in JPPM may be accompanied by lay-level summaries, to assist patients, caregivers, and others in understanding important medical advances.

From the journal's Aims & Scope

Editor-in-chief Majid DavariPublisher website

Editorial board by country: none in mainland China; most named Iran 18, Denmark 1, Pakistan 1 (20 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance27.2%
  2. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance17.5%
  3. Healthcare Systems and ReformsEconomics, Econometrics and Finance6.8%
  4. Antibiotic Use and ResistanceImmunology and Microbiology3.9%
  5. Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics3.9%
  6. Global trade and economicsEconomics, Econometrics and Finance2.9%
  7. Antibiotics Pharmacokinetics and EfficacyMedicine2.9%
  8. Long-Term Effects of COVID-19Medicine2.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
1OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0.06OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 53 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026001
202523232
2024993
202320201

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 12 weeksLetPub ·
Submission to publication (journal-reported)
about 12 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted1
  1. original articleA Descriptive Study of Medicine Utilisation in Côte D’ivoire JEROME KOUAME , Régine Attia-Konan , Kouame Koffi , Paul Yapo Yapi , Serge Oga XML | PDF | download…Length not stated
Publisher website

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Tehran University of Medical Sciences
Country or region
Iran, Islamic Republic of
Language
English
ISSN
2383-4498
Latest issue on the website
Volume 11, Issue 2 (2025)
Official links

FAQ

Frequently asked questions about Journal of Pharmacoeconomics and Pharmaceutical Management

How long does peer review take at Journal of Pharmacoeconomics and Pharmaceutical Management?

Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Journal of Pharmacoeconomics and Pharmaceutical Management based?

Of the 20 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (18), Denmark (1) and Pakistan (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Journal of Pharmacoeconomics and Pharmaceutical Management?

According to LetPub and DOAJ records, Journal of Pharmacoeconomics and Pharmaceutical Management is indexed in DOAJ.

Is Journal of Pharmacoeconomics and Pharmaceutical Management open access, and what is the APC?

Journal of Pharmacoeconomics and Pharmaceutical Management is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .